Prognostic value of KRAS mutations, TP53 mutations and PD-L1 expression among lung adenocarcinomas treated with immunotherapy
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Pathology"
DOI: 10.1136/jcp-2022-208574
Abstract: Aims The aim of this study was to investigate the association between oncogenic alterations and programmed cell death ligand 1 (PD-L1) expression in lung adenocarcinomas, as well as the prognostic value of KRAS and/or TP53… read more here.
Keywords: mutations tp53; mutations expression; treated immunotherapy; lung adenocarcinomas ... See more keywords
Abstract 4650: The impact of GLI3 mutations and expression on prognosis in gastric cancer
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-4650
Abstract: GLI3, a member of the GLI zinc finger family, has been extensively investigated in various cancers, including gastric cancer. It has been observed that GLI3 is significantly upregulated in solid cancer types. These findings suggest… read more here.
Keywords: gli3 mutations; cancer; mutations expression; prognosis ... See more keywords
Radiogenomic System for Non-Invasive Identification of Multiple Actionable Mutations and PD-L1 Expression in Non-Small Cell Lung Cancer Based on CT Images
Sign Up to like & getrecommendations! Published in 2022 at "Cancers"
DOI: 10.3390/cancers14194823
Abstract: Simple Summary Actional mutations and PD-L1 expression are of paramount importance for the precision treatment of lung cancer. Radiogenomics is a promising field that integrated radiologic images and genomic data through artificial intelligence technology. This… read more here.
Keywords: system; lung cancer; deep learning; mutations expression ... See more keywords